Alpha-2 (α2) inhibition of osmotic water permeability (Pf) in the rat cortical collecting duct (CCD)

Research output: Contribution to journalArticle

Abstract

The objective of this study was to determine if dexmedetomidine (dex) a selective n% agonist, inhibits Pp in the rat CCD when P p is stimulated by the nonhydrolyzable cyclic-AMP analog 8-p-(chlorophenylthio) cychc AMP (CPTcAMP). Pp was determined in Sprague-Dawley rat CCDs via the isolated perfused tubule technique. CPT-cAMP at IO-4M added to the bath raised Pp (fun/sec) from 0 to 651±75 (p< .001) (n=6). Dex at 100 nM added to the bath lowered Pp to 396±92 (p<.05). The addition of 100 nM atipamezole (ati), a selective 02 antagonist, raised Pp to 526±114, These data substantiate previous findings showing that epinephrine inhibits bromoadenosine-cAMPstimulated Pp via an ag mechanism (Hawk et al., Am. J. Physiol. 265:F449, 1993). We also measured dex-induced inhibition of arginine vasopressin (AVP)-stimulated Pp in the presence of the protein kinase C (PKC) inhibitor staurosporine (ST). AVP at 220 pM added to the bath raised Pp from 0 to 605±82 (p<.001) (n=6). Dex at 100 nM with 10'-4 ST in the bath lowered Pp to 145±31 and the addition of 100 nM ati raised Pp to 558±103. Thus, dex reduced AVP-stimulated Pp by 76%, not 100% as previously reported without ST in the bath (Rouch & Kudo, FASEB J. 8:A551, 1994). We conclude that dexmedetomidine significantly inhibits P p in the rat CCD in the presence of constant cellular cAMP levels. This indicates that second messengers other than cAMP are involved in 2 inhibition of Pp and one such messenger could be PKC. This study was supported by NSF grant IBN 9507444.

Original languageEnglish
JournalFASEB Journal
Volume10
Issue number3
StatePublished - 1 Dec 1996

Fingerprint

dexmedetomidine
Dexmedetomidine
arginine vasopressin
Baths
Ducts
Staurosporine
Arginine Vasopressin
Rats
Permeability
permeability
Water
rats
protein kinase C
Protein Kinase C
water
second messengers
cyclic AMP
Second Messenger Systems
epinephrine
Adenosine Monophosphate

Cite this

@article{4fb5ba57e2814024b5c7a7d02a602935,
title = "Alpha-2 (α2) inhibition of osmotic water permeability (Pf) in the rat cortical collecting duct (CCD)",
abstract = "The objective of this study was to determine if dexmedetomidine (dex) a selective n{\%} agonist, inhibits Pp in the rat CCD when P p is stimulated by the nonhydrolyzable cyclic-AMP analog 8-p-(chlorophenylthio) cychc AMP (CPTcAMP). Pp was determined in Sprague-Dawley rat CCDs via the isolated perfused tubule technique. CPT-cAMP at IO-4M added to the bath raised Pp (fun/sec) from 0 to 651±75 (p< .001) (n=6). Dex at 100 nM added to the bath lowered Pp to 396±92 (p<.05). The addition of 100 nM atipamezole (ati), a selective 02 antagonist, raised Pp to 526±114, These data substantiate previous findings showing that epinephrine inhibits bromoadenosine-cAMPstimulated Pp via an ag mechanism (Hawk et al., Am. J. Physiol. 265:F449, 1993). We also measured dex-induced inhibition of arginine vasopressin (AVP)-stimulated Pp in the presence of the protein kinase C (PKC) inhibitor staurosporine (ST). AVP at 220 pM added to the bath raised Pp from 0 to 605±82 (p<.001) (n=6). Dex at 100 nM with 10'-4 ST in the bath lowered Pp to 145±31 and the addition of 100 nM ati raised Pp to 558±103. Thus, dex reduced AVP-stimulated Pp by 76{\%}, not 100{\%} as previously reported without ST in the bath (Rouch & Kudo, FASEB J. 8:A551, 1994). We conclude that dexmedetomidine significantly inhibits P p in the rat CCD in the presence of constant cellular cAMP levels. This indicates that second messengers other than cAMP are involved in 2 inhibition of Pp and one such messenger could be PKC. This study was supported by NSF grant IBN 9507444.",
author = "L. Kudo and Alexander Rouch",
year = "1996",
month = "12",
day = "1",
language = "English",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

Alpha-2 (α2) inhibition of osmotic water permeability (Pf) in the rat cortical collecting duct (CCD). / Kudo, L.; Rouch, Alexander.

In: FASEB Journal, Vol. 10, No. 3, 01.12.1996.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Alpha-2 (α2) inhibition of osmotic water permeability (Pf) in the rat cortical collecting duct (CCD)

AU - Kudo, L.

AU - Rouch, Alexander

PY - 1996/12/1

Y1 - 1996/12/1

N2 - The objective of this study was to determine if dexmedetomidine (dex) a selective n% agonist, inhibits Pp in the rat CCD when P p is stimulated by the nonhydrolyzable cyclic-AMP analog 8-p-(chlorophenylthio) cychc AMP (CPTcAMP). Pp was determined in Sprague-Dawley rat CCDs via the isolated perfused tubule technique. CPT-cAMP at IO-4M added to the bath raised Pp (fun/sec) from 0 to 651±75 (p< .001) (n=6). Dex at 100 nM added to the bath lowered Pp to 396±92 (p<.05). The addition of 100 nM atipamezole (ati), a selective 02 antagonist, raised Pp to 526±114, These data substantiate previous findings showing that epinephrine inhibits bromoadenosine-cAMPstimulated Pp via an ag mechanism (Hawk et al., Am. J. Physiol. 265:F449, 1993). We also measured dex-induced inhibition of arginine vasopressin (AVP)-stimulated Pp in the presence of the protein kinase C (PKC) inhibitor staurosporine (ST). AVP at 220 pM added to the bath raised Pp from 0 to 605±82 (p<.001) (n=6). Dex at 100 nM with 10'-4 ST in the bath lowered Pp to 145±31 and the addition of 100 nM ati raised Pp to 558±103. Thus, dex reduced AVP-stimulated Pp by 76%, not 100% as previously reported without ST in the bath (Rouch & Kudo, FASEB J. 8:A551, 1994). We conclude that dexmedetomidine significantly inhibits P p in the rat CCD in the presence of constant cellular cAMP levels. This indicates that second messengers other than cAMP are involved in 2 inhibition of Pp and one such messenger could be PKC. This study was supported by NSF grant IBN 9507444.

AB - The objective of this study was to determine if dexmedetomidine (dex) a selective n% agonist, inhibits Pp in the rat CCD when P p is stimulated by the nonhydrolyzable cyclic-AMP analog 8-p-(chlorophenylthio) cychc AMP (CPTcAMP). Pp was determined in Sprague-Dawley rat CCDs via the isolated perfused tubule technique. CPT-cAMP at IO-4M added to the bath raised Pp (fun/sec) from 0 to 651±75 (p< .001) (n=6). Dex at 100 nM added to the bath lowered Pp to 396±92 (p<.05). The addition of 100 nM atipamezole (ati), a selective 02 antagonist, raised Pp to 526±114, These data substantiate previous findings showing that epinephrine inhibits bromoadenosine-cAMPstimulated Pp via an ag mechanism (Hawk et al., Am. J. Physiol. 265:F449, 1993). We also measured dex-induced inhibition of arginine vasopressin (AVP)-stimulated Pp in the presence of the protein kinase C (PKC) inhibitor staurosporine (ST). AVP at 220 pM added to the bath raised Pp from 0 to 605±82 (p<.001) (n=6). Dex at 100 nM with 10'-4 ST in the bath lowered Pp to 145±31 and the addition of 100 nM ati raised Pp to 558±103. Thus, dex reduced AVP-stimulated Pp by 76%, not 100% as previously reported without ST in the bath (Rouch & Kudo, FASEB J. 8:A551, 1994). We conclude that dexmedetomidine significantly inhibits P p in the rat CCD in the presence of constant cellular cAMP levels. This indicates that second messengers other than cAMP are involved in 2 inhibition of Pp and one such messenger could be PKC. This study was supported by NSF grant IBN 9507444.

UR - http://www.scopus.com/inward/record.url?scp=33749092749&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749092749

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -